Precision Prevention Studies: A Targeted Approach to Cancer Prevention

Sarah P. Blagden(Churchill Hospital), Éva Szabó(National Cancer Institute), Karen Brown(University of Leicester), Kevin W. Dodd(National Cancer Institute)

Cancer Prevention Research

July 6, 2025

10.1158/1940-6207.capr-25-0035

Cited by 5

Related Papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

|Nature reviews. Cancer|2015|1.4k

What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol

|PLoS ONE|2011|437

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

|The Lancet|2019|223

Performance status score: do patients and their oncologists agree?

|British Journal of Cancer|2003|222

La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs

|eLife|2017|201